Experiments by Ghoneum and Agrawal [81] further demonstrated that CD8+ T cells cultured with BioBran MGN3-activated DC had increased cytotoxicity against tumour cell targets significantly (p < 0.05) compared to those treated with unstimulated DC. The gene discussed is CD8A; the disease is neoplasm.